Today's Pre-Market Stock Movers: F, BNTX, MRNA, CHNG and More
Gapping up
In reaction to earnings/guidance:
Other news:
• $Change Healthcare(CHNG.US$ +7.5% (a federal judge ruled against the Justice Department’s antitrust challenge to $UnitedHealth(UNH.US$ planned $13 billion acquisition of the company)
• $Perpetua Resources(PPTA.US$ +6.1% (receives DOD funding to study antimony from Stibnite Gold Project)
• $Ouster(OUST.US$ +2.6% (announced a comprehensive cost reduction initiative across its business streamlining its cost structure and extending its expected cash runway)
• $Decibel Therapeutics(DBTX.US$ +2.3% (submission of an Investigational New Drug application for a Phase 1/2 clinical trial in pediatric patients of DB-OTO)
• $Boeing(BA.US$ +2.2% (met with regulators in China about returning 737 Max to flight according to Reuters)
• $Wave Life Sciences(WVE.US$ +2.1% (update to the ongoing Phase lb/2a SELECT-HD clinical trial of WVE-003 the company’s clinical candidate for Huntington's disease)
• $America Movil SAB de CV(AMX.US$ +1% (informs about the listing of Sitios Latinoamrica S.A.B. de C.V. incorporated as result of AMX's spin-off (Sitios Latam); also upgraded to Buy from Neutral at UBS)
Gapping down
In reaction to earnings/guidance:
• $Ford Motor(F.US$ -4.8% (reaffirms FY22 EBIT but inflation-related supplier costs to run $1 bln higher than expected)
Other news:
• $Invitae(NVTA.US$ -4.2% (reports real-world ciitizen data utilized in Praxis Precision Medicines' PR.AX-222 IND Filing)
• $BioNTech(BNTX.US$, $Moderna(MRNA.US$ – The vaccine makers are seeing shares fall again this morning, after sliding yesterday on President Joe Biden’s comment that the pandemic was "over."
• $BioNTech(BNTX.US$, $Moderna(MRNA.US$ – The vaccine makers are seeing shares fall again this morning, after sliding yesterday on President Joe Biden’s comment that the pandemic was "over."
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment